Cargando…
Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients
BACKGROUND: We have previously shown bone marrow-derived mesenchymal stem cells (MSCs) may shift immune responses toward anti-inflammatory pathways and stabilize the course of obstructive chronic lung allograft syndrome (o-CLAD) after lung transplantation. In this study, we measured the response of...
Autores principales: | Erasmus, David Brett, Durand, Nisha, Alvarez, Francisco A, Narula, Tathagat, Hodge, David O, Zubair, Abba C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492292/ https://www.ncbi.nlm.nih.gov/pubmed/35881142 http://dx.doi.org/10.1093/stcltm/szac051 |
Ejemplares similares
-
Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction
por: Keller, Cesar Ariel, et al.
Publicado: (2018) -
Antithymocyte globulin is associated with a lower incidence of de novo donor‐specific antibody detection in lung transplant recipients: A single‐center experience
por: Narula, Tathagat, et al.
Publicado: (2021) -
Effect of Comedications and Endotoxins on Mesenchymal Stem Cell Secretomes, Migratory and Immunomodulatory Capacity
por: Durand, Nisha, et al.
Publicado: (2019) -
Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure
por: Durand, Nisha, et al.
Publicado: (2020) -
Successful lung transplantation from a donor with lung and ovarian masses
por: Asif, Abuzar A, et al.
Publicado: (2019)